Moreover, FGF19 and BIRC5 were concomitantly overexpressed in all 10 of these tumour samples, further establishing a positive correlation between the expression of FGF19 and BIRC5, a STAT3 target gene, in human HCC. This evidence concerns the gene BIRC5 and hepatocellular carcinoma.